title: Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo.
abstract: We have constructed recombinant adenoviruses (Ad), with functional or defective E1a genes, which harbor either the hepatitis B (HB) virus s gene encoding the HB surface antigen, as well as the pre-S2 epitopes, or the bacterial gene encoding chloramphenicol acetyltransferase (CAT) under control of the Ad major late promoter (MLP). The recombinant viruses defective for E1a (Ad.MLP.S2 and Ad.CAT), which can be efficiently propagated only on 293 cells that complement this defect, and the nondefective (Ad.MLP.S2.E1A) recombinant were used to infect a wide spectrum of cells of different origin. The yields of HBs and CAT proteins obtained with these different recombinant viruses demonstrate no real advantage to using nondefective vectors, whatever the cell type infected. The injection into chimpanzees of Ad.MLP.S2 does not elicit the production of antibodies, but can immunologically prime the animals, resulting in a partial protection against HBV challenge.
authors.affiliation: Unité Associée 1301 du CNRS, Institut Gustave Roussy, Villejuif, France.
authors.forename: M
authors.initials: M
authors.lastname: Levrero
authors.forename: V
authors.initials: V
authors.lastname: Barban
authors.forename: S
authors.initials: S
authors.lastname: Manteca
authors.forename: A
authors.initials: A
authors.lastname: Ballay
authors.forename: C
authors.initials: C
authors.lastname: Balsamo
authors.forename: M L
authors.initials: ML
authors.lastname: Avantaggiati
authors.forename: G
authors.initials: G
authors.lastname: Natoli
authors.forename: H
authors.initials: H
authors.lastname: Skellekens
authors.forename: P
authors.initials: P
authors.lastname: Tiollais
authors.forename: M
authors.initials: M
authors.lastname: Perricaudet
mesh_terms: D000260:Adenoviruses, Human / Q000235:genetics* / Q000502:physiology; D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics; D004274:DNA, Recombinant / Q000235:genetics; D003673:Defective Viruses / Q000235:genetics; D015870:Gene Expression / Q000235:genetics; D005822:Genetic Vectors; D006509:Hepatitis B / Q000517:prevention & control; D006514:Hepatitis B Surface Antigens / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology; D017325:Hepatitis B Vaccines; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D002679:Pan troglodytes; D011401:Promoter Regions, Genetic; D011817:Rabbits; D014407:Tumor Cells, Cultured; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines; D014779:Virus Replication
chemical_list: D004274:DNA, Recombinant; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines; D015500:Chloramphenicol O-Acetyltransferase